- Home
- GLPG vs INOD Comparison
GLPG vs INOD Comparison
Compare GLPG & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- INOD
- Stock Information
- Founded
- GLPG 1999
- INOD 1988
- Country
- GLPG Belgium
- INOD United States
- Employees
- GLPG N/A
- INOD N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- INOD EDP Services
- Sector
- GLPG Health Care
- INOD Technology
- Exchange
- GLPG Nasdaq
- INOD Nasdaq
- Market Cap
- GLPG 1.8B
- INOD 2.0B
- IPO Year
- GLPG 2005
- INOD 1993
- Fundamental
- Price
- GLPG $26.86
- INOD $38.07
- Analyst Decision
- GLPG Sell
- INOD Strong Buy
- Analyst Count
- GLPG 4
- INOD 4
- Target Price
- GLPG $25.33
- INOD $55.00
- AVG Volume (30 Days)
- GLPG 419.6K
- INOD 1.6M
- Earning Date
- GLPG 04-23-2025
- INOD 05-08-2025
- Dividend Yield
- GLPG N/A
- INOD N/A
- EPS Growth
- GLPG N/A
- INOD N/A
- EPS
- GLPG N/A
- INOD 0.89
- Revenue
- GLPG $311,493,731.00
- INOD $170,461,000.00
- Revenue This Year
- GLPG $0.08
- INOD $44.96
- Revenue Next Year
- GLPG $0.23
- INOD $20.78
- P/E Ratio
- GLPG N/A
- INOD $42.78
- Revenue Growth
- GLPG 18.32
- INOD 96.44
- 52 Week Low
- GLPG $22.36
- INOD $5.68
- 52 Week High
- GLPG $31.23
- INOD $71.00
- Technical
- Relative Strength Index (RSI)
- GLPG 67.75
- INOD 51.64
- Support Level
- GLPG $24.31
- INOD $29.13
- Resistance Level
- GLPG $24.91
- INOD $39.88
- Average True Range (ATR)
- GLPG 0.82
- INOD 3.51
- MACD
- GLPG 0.34
- INOD 0.72
- Stochastic Oscillator
- GLPG 97.49
- INOD 86.56
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About INOD Innodata Inc.
Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.